LSTA
Lisata Therapeutics Inc.
NASDAQ: LSTA · HEALTHCARE · BIOTECHNOLOGY
$3.12
-3.11% today
Updated 2026-04-30
Market cap
$28.18M
P/E ratio
—
P/S ratio
165.77x
EPS (TTM)
$-1.91
Dividend yield
—
52W range
$2 – $5
Volume
0.1M
Lisata Therapeutics Inc. (LSTA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,079.00%
ROE
-75.50%
ROA
-43.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $45724.00 | $-6.05M | 51.01% | -10,259.38% | -13,233.75% |
| 2007 | $231664.00 | $-10.45M | 89.27% | -4,506.02% | -4,508.89% |
| 2008 | $83541.00 | $-9.24M | 61.72% | -11,052.60% | -11,062.92% |
| 2009 | $11.56M | $-26.17M | 34.40% | -223.68% | -226.29% |
| 2010 | $69.82M | $-23.31M | 28.86% | -27.04% | -33.38% |
| 2011 | $10.05M | $-47.13M | 13.96% | -338.36% | -469.00% |
| 2012 | $14.33M | $-54.78M | 16.62% | -212.04% | -382.29% |
| 2013 | $14.67M | $-38.98M | 11.73% | -250.93% | -265.74% |
| 2014 | $17.94M | $-54.87M | 12.60% | -321.87% | -305.89% |
| 2015 | $22.49M | $-80.89M | 10.36% | -229.35% | -359.69% |
| 2016 | $35.28M | $-32.66M | 11.76% | -88.81% | -92.55% |
| 2017 | — | $22.98M | — | — | — |
| 2018 | $0.00 | $-16.17M | — | — | — |
| 2019 | $0.00 | $-20.10M | — | — | — |
| 2020 | $0.00 | $-8.15M | — | — | — |
| 2021 | $0.00 | $-27.47M | — | — | — |
| 2022 | $121.37M | $-54.23M | 52.54% | -47.46% | -44.68% |
| 2023 | $0.00 | $-20.84M | — | — | — |
| 2024 | $1.00M | $-19.98M | 100.00% | -2,240.90% | -1,998.50% |
| 2025 | $170000.00 | $-16.59M | 14.12% | -10,711.18% | -9,756.47% |